CytoMed Therapeutics Limited Other Gains Losses
CytoMed Therapeutics Limited (GDTC) reported Other Gains Losses of SGD 140.32 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Income Statement › Other Income
ifrs-full:OtherGainsLosses · last filed 2026-03-31
SGD
| Period end | Other Gains Losses 12 month |
|---|---|
| 2025-12-31 | 140.32K SGD 20-F · filed 2026-03-31 |
| 2024-12-31 | 297.55K SGD 20-F · filed 2026-03-31 |
| 2023-12-31 | -492.91K SGD 20-F · filed 2026-03-31 |
| 2022-12-31 | -1.12M SGD 20-F · filed 2025-04-28 |
| 2021-12-31 | 3.19K SGD 20-F · filed 2024-04-22 |
| 2020-12-31 | -573.86K SGD 20-F · filed 2023-05-01 |
USD
| Period end | Other Gains Losses 12 month |
|---|---|
| 2025-12-31 | $109.12K 20-F · filed 2026-03-31 |
| 2024-12-31 | $217.79K 20-F · filed 2025-04-28 |
| 2023-12-31 | -$373.62K 20-F · filed 2024-04-22 |
| 2022-12-31 | -$833.05K 20-F · filed 2023-05-01 |